GENERALIZED MYASTHENIA GRAVIS (GMG)

Clinical trials for GENERALIZED MYASTHENIA GRAVIS (GMG) explained in plain language.

Never miss a new study

Get alerted when new GENERALIZED MYASTHENIA GRAVIS (GMG) trials appear

Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS (GMG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet finished but already full! 1 Completed 1

One-Shot immune reset: early trial tests CAR-T therapy for debilitating muscle disease

Disease control Ongoing

This early-phase study is testing an investigational one-time cell therapy called CABA-201 in adults with generalized myasthenia gravis (gMG), a rare autoimmune disease that causes severe muscle weakness. The therapy aims to reset the immune system by removing the harmful B cells…

Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)

Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

GENERALIZED MYASTHENIA GRAVIS (GMG)

Get alerted when new GENERALIZED MYASTHENIA GRAVIS (GMG) trials appear

One-Shot immune reset: early trial tests CAR-T therapy for debilitating muscle disease